Xenova
Executive Summary
Linda Fellows, formerly had of biochemistry section at Britain's Royal Botanical Gardens at Kew, joins in new position of program head of phytopharmaceuticals. At Kew, Fellows conducted research that resulted in the discovery of the anti-HIV effects of n-butyl-deoxynojirimycin, a plant alkaloid derivative that is currently in clinical trials. U.K.-based Xenova, which focuses on small molecule therapeutics that are microbe-derived, has drug discovery collaborators including Genentech, Warner-Lambert, Genzyme and Suntory.